Ehrlichia chaffeensis-associated Hemophagocytic Lymphohistiocytosis: A Case Series and Literature Review

Tasaduq Fazili^1, , Ekta Bansal¹, Dorothy Garner¹, Vijayendra Bajwa¹, Harpreet Kaur² and Charles Schleupner¹

¹Virginia Tech Carilion School of Medicine, Section of Infectious Diseases, Department of Medicine, Carilion Clinic, Roanoke, VA 24014, USA

²Virginia Tech Carilion School of Medicine, Department of Medicine, Carilion Clinic, Roanoke, VA 24014, USA

Cite this paper

Tasaduq Fazili, Ekta Bansal, Dorothy Garner, Vijayendra Bajwa, Harpreet Kaur and Charles Schleupner. Ehrlichia chaffeensis-associated Hemophagocytic Lymphohistiocytosis: A Case Series and Literature Review. American Journal of Medical Case Reports. 2021; 9(11):557-563. doi: 10.12691/AJMCR-9-11-11

Abstract

Introduction: Hemophagocytic lymphohistiocytosis (HLH) is an uncommon condition characterized by abnormal, excessive immune activation resulting in severe cytopenias from an uncontrolled inflammatory response. It can be primary/ familial or secondary/sporadic. Infections, particularly viral infections are a common cause of secondary HLH. HLH due to Human monocytic ehrlichiosis (HME) is very rare, hence we are reporting our cases. Objective: To review cases of Ehrlichia-associated HLH at our institution and perform a literature review regarding this entity. Methods: We reviewed cases of Ehrlichia-associated HLH for the previous two years at our institution (Carilion Clinic). We then performed a review of the published literature on it, using Pubmed. Results: Over the past two years, five cases of Ehrlichia-associated HLH were diagnosed at our hospital. The average age of the patients was 67 years with predominantly males. All the patients were pancytopenic, and a majority had abnormal liver function tests. Diagnosis of ehrlichiosis was made by serum polymerase chain reaction (PCR) assay on blood. Patients had further testing done because of lack of clinical improvement. All patients had significantly elevated ferritin levels. Bone marrow biopsy samples of all patients showed findings of hemophagocytosis. All, but one, patients were treated with doxycycline and a combination of etoposide and dexamethasone. Three patients recovered while two died. On review of medical literature, we found a total of only 36 cases of Ehrlichia-associated HLH, including our five cases. There were 19 adults and 17 children. Both population groups showed varying degrees of pancytopenia. Splenomegaly was relatively uncommon, seen in less than one-third of the patients. Ferritin and triglyceride levels were routinely elevated. Bone marrow biopsy showing hemophagocytosis was the confirmatory test in all patients. A significant number of patients, both adults and children, required a combination of doxycycline and chemotherapy (etoposide and dexamethasone) to achieve clinical cure. Children had a better prognosis than adults, with one child and four adults succumbing to their illness. Conclusions: Ehrlichia-associated HLH is a rare but emerging disease entity. In endemic areas, a high degree of suspicion is required to diagnose ehrlichiosis and HLH resulting from it. Early diagnosis and prompt initiation of treatment for HLH is key to a favorable outcome.

Keywords

Ehrlichia, hemophagocytic lymphohistiocytosis, HLH

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Ohl CA; Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006 Mar 31; 55(RR-4): 1-27.
[2]	Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med. 1987 Apr 2; 316(14): 853-6.
[3]	Dumler JC, Madigan JE, Pusterla N, and Bakken JS. Ehrlichioses in Humans: Epidemiology, Clinical Presentation, Diagnosis, and Treatment. Clin Infect Dis 2007; 45: S45-51.
[4]	Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and Laboratory Spectrum of Culture-Proven Human Granulocytic Ehrlichiosis: Comparison with Culture-Negative Cases. Clin Infect Dis. 1998; 27: 1314-7.
[5]	Standaert SM, Yu T, Scott MA, et al. Primary Isolation of Ehrlichia chaffeensis from Patients with Febrile Illnesses: Clinical and Molecular Characteristics. J Infect Dis 2000; 181:1082-8.
[6]	Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in Persons Coinfected with Human Immunodeficiency Virus. Clin Infect Dis 2001; 33: 1586-94.
[7]	Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014 Apr 26; 383(9927): 1503-1516.
[8]	Henter J, Horne AC, Arico M, Egeler M, Filipovich A, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
[9]	Badireddi S, Joshi M. Hemophagocytic Lymphohistiocytosis: An Unreported Complication of Ehrlichiosis in Adults. Chest 2012; 142(4_Meeting Abstracts): 415A.
[10]	Otrock Z, Gonzalez M, Eby C. Ehrlichia-induced hemophagocytic lymphohistiocytosis: A case series and review of literature. Blood Cells, Molecules and Diseases 2015(55): 191-193.
[11]	Otrock Z, Eby C, Burnham C. Human ehrlichiosis at a tertiary-care academic medical center: Clinical associations and outcomes of transplant patients and patients with hemophagocytic lymphohistiocytosis. Blood Cells, Molecules and Diseases. 2019 (77): 17-22.
[12]	Naqash A, Yogarajah M, Vallangeon B, Hafiz M, Patel D, Kolychev E, Lebron D, Liles D. Hemophagocytic lymphohistiocytosis (HLH) secondary to Ehrlichia chaffeensis with bone marrow involvement. Ann Hematol 2017; 96: 1755-1758.
[13]	Pandey R, Kochar R, Kemp S, Rotaru D, Shah S. Ehrlichiosis presenting with toxic shock-like syndrome and secondary hemophagocytic lymphohistiocytosis. J Arkansas Med Scociety. 2013; 109: 280-282.
[14]	Kumar N, Goyal J, Goel A, Shakoory B, Chatham W. Macrophage activation syndrome secondary to human monocytic ehrlichiosis. Indian J Hematol Blood Transfus 2014; 30(Suppl 1): S145-S147.
[15]	Kaplan R, Swat S, Singer B. Human monocytic ehrlichiosis complicated by hemophagocytic lymphohistiocytosis and multi-organ dysfunction syndrome. Diagn Microbiol Infect Dis. 2016; 86(3): 327-328.
[16]	Provenzano J, Kamerzell T, Reda E, Hawkinson D, Sharpe M. Diagnosis and treatment of hemophagocytic lymphohistiocytosis in adult patient with ehrlichiosis. Case Rep Intern Med 2015; 2(2): 44.
[17]	Patel P, Beck P, Chairman D, Regunath H. Ehrlichiosis presenting as hemophagocytic lymphohistiocytosis in an immunocompetent adult. ID Cases 2020; 20: e00813.
[18]	Higuita N, Yuen C. Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis in adults: A case series from Oklahoma. Am J Med Sci 2020; S0002-9629(20) 30396-7.
[19]	Burns S, Saylors R, Mian A. Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis infection: A case report. J Pediatr Hematol Oncol 2010; 32: e142-e143.
[20]	Hanson D, Walter A, Powell J. Ehrlichia-induced hemophagocytic lymphohistiocytosis in two children. Pediatr Blood Cancer 2011; 56: 661-663.
[21]	Cheng A, Williams F, Fortenberry J, Preissig C, Salinas S, Kamat P. Use of extracorporeal support in hemophagocytic lymphohistiocytosis secondary to Ehrlichiosis. Pediatrics 2016; 138(4): e20154176.
[22]	Cabler S, Hogan P, Fritz S, Bednarski J, Hunstad D. Incidence and treatment of hemophagocytic lymphohistiocytosis in hospitalized children with Ehrlichia infection. Pediatr Blood Cancer 2020; 67: e28436.